跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Halaven - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Halaven
Approved
STANDARD
Halaven
NerPharma S.r.l.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a5cd8a25d5484ffc
Company
NerPharma S.r.l.
Type
Standard
Approval Details
Approval Id
a5cd8a25d5484ffc
Drug Approval Philippines Name
Halaven
Product Name
Halaven
Registration Number
DR-XY41784
Brand Name
Halaven
Generic Name
Eribulin Mesilate
Dosage Form
Solution for Injection (I.V.)
Dosage Strength
500 mcg/mL (1 mg/2 mL)
Manufacturer
NerPharma S.r.l.
Importer
HI-Eisai Pharmaceutical, Inc.
Distributor
Zuellig Pharma Corp.
Company Detail Path
/organization/nerpharma-srl
Issuance Date
03 November 2021
Expiry Date
11 March 2026
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a5cd8a25d5484ffc
Type
Standard
Back to Philippines FDA Approvals